In this week's #AskDrDurie video, IMF Chairman Dr. Brian Durie discusses how intravenous immunoglobulin is being used as a treatment option for multiple myeloma.

Image of Dr. Brian G.M. DurieDr. Brian G.M. Durie serves as Chairman of the International Myeloma Foundation and serves on its Scientific Advisory Board. Additionally, he is Chairman of the IMF's International Myeloma Working Group, a consortium of nearly 200 myeloma experts from around the world. Dr. Durie also leads the IMF’s Black Swan Research Initiative®.

Previous Post
Is chiropractic care an option for patients with myeloma?
Next Post
Remembering Mike Katz, a Very Special Patient Advocate

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.